215 related articles for article (PubMed ID: 15048623)
21. Computerized morphometry of mean nuclear diameter and nuclear roundness in canine mammary gland tumors on cytologic smears.
Simeonov R; Simeonova G
Vet Clin Pathol; 2006 Mar; 35(1):88-90. PubMed ID: 16511796
[TBL] [Abstract][Full Text] [Related]
22. MIB-1 labelling indices according to clinico-pathological variables in canine mammary tumours: a multivariate study.
De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Dos Santos MS; Rutteman GR; Gärtner Mde F
Anticancer Res; 2006; 26(3A):1821-6. PubMed ID: 16827113
[TBL] [Abstract][Full Text] [Related]
23. Cellular proliferative and telomerase activity in canine mammary gland tumors.
Funakoshi Y; Nakayama H; Uetsuka K; Nishimura R; Sasaki N; Doi K
Vet Pathol; 2000 Mar; 37(2):177-83. PubMed ID: 10714647
[TBL] [Abstract][Full Text] [Related]
24. Detection of lymph node micrometastases in malignant mammary tumours in dogs by cytokeratin immunostaining.
Matos AJ; Faustino AM; Lopes C; Rutteman GR; Gärtner F
Vet Rec; 2006 May; 158(18):626-30. PubMed ID: 16679481
[TBL] [Abstract][Full Text] [Related]
25. Ceramide galactosyltransferase (UGT8) as a molecular marker of canine mammary tumor malignancy.
Nowak M; Dziegiel P; Madej J; Ugorski M
Folia Histochem Cytobiol; 2013; 51(2):164-7. PubMed ID: 23907947
[TBL] [Abstract][Full Text] [Related]
26. Myoepithelial cells and extracellular matrix in the cytologic differentiation of canine mammary tumors.
Emanuelli MP; Kommers GD; Antoniazzi AQ; Bernardes FCS; Lopes STA; Fighera RA
Vet Clin Pathol; 2020 Sep; 49(3):451-458. PubMed ID: 32966632
[TBL] [Abstract][Full Text] [Related]
27. Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study.
Canadas A; França M; Pereira C; Vilaça R; Vilhena H; Tinoco F; Silva MJ; Ribeiro J; Medeiros R; Oliveira P; Dias-Pereira P; Santos M
Vet Pathol; 2019 Mar; 56(2):208-219. PubMed ID: 30381007
[TBL] [Abstract][Full Text] [Related]
28. Immunocytochemical differentiation of canine mesenchymal tumors in cytologic imprint preparations.
Höinghaus R; Hewicker-Trautwein M; Mischke R
Vet Clin Pathol; 2008 Mar; 37(1):104-11. PubMed ID: 18366552
[TBL] [Abstract][Full Text] [Related]
29. MIB-1 labeling index in feline dysplastic and neoplastic mammary lesions and its relationship with postsurgical prognosis.
Millanta F; Lazzeri G; Mazzei M; Vannozzi I; Poli A
Vet Pathol; 2002 Jan; 39(1):120-6. PubMed ID: 12102203
[TBL] [Abstract][Full Text] [Related]
30. Immunocytochemical detection of Ki-67 in Diff-Quik-stained cytological smears of canine mammary gland tumours.
Choi US; Kim DY
Cytopathology; 2011 Apr; 22(2):115-20. PubMed ID: 20545725
[TBL] [Abstract][Full Text] [Related]
31. Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.
de Araújo MR; Campos LC; Ferreira E; Cassali GD
J Vet Intern Med; 2015; 29(5):1360-7. PubMed ID: 26130166
[TBL] [Abstract][Full Text] [Related]
32. Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs.
Ferreira E; Gobbi H; Saraiva BS; Cassali GD
Vet Pathol; 2012 Mar; 49(2):322-9. PubMed ID: 21282668
[TBL] [Abstract][Full Text] [Related]
33. The accuracy of cytology in diagnosis and DNA analysis of canine mammary tumours.
Hellmén E; Lindgren A
J Comp Pathol; 1989 Nov; 101(4):443-50. PubMed ID: 2607016
[TBL] [Abstract][Full Text] [Related]
34. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors.
Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK
J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological significance of caspase-3 and Ki-67 expression in canine mammary gland tumours.
Rodrigues H; Carvalho MI; Pires I; Prada J; Queiroga FL
Acta Vet Hung; 2016 Mar; 64(1):78-89. PubMed ID: 26919145
[TBL] [Abstract][Full Text] [Related]
36. Classification and behavior of canine mammary epithelial neoplasms based on life-span observations in beagles.
Benjamin SA; Lee AC; Saunders WJ
Vet Pathol; 1999 Sep; 36(5):423-36. PubMed ID: 10490210
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases.
Hellmén E; Bergström R; Holmberg L; Spångberg IB; Hansson K; Lindgren A
Vet Pathol; 1993 Jan; 30(1):20-7. PubMed ID: 8442324
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of tissue and serum HER2 and MUC1 in canine mammary cancer.
Campos LC; Silva JO; Santos FS; Araújo MR; Lavalle GE; Ferreira E; Cassali GD
J Vet Diagn Invest; 2015 Jul; 27(4):531-5. PubMed ID: 26179096
[TBL] [Abstract][Full Text] [Related]
39. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
[TBL] [Abstract][Full Text] [Related]
40. Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors.
Nguyen F; Peña L; Ibisch C; Loussouarn D; Gama A; Rieder N; Belousov A; Campone M; Abadie J
Breast Cancer Res Treat; 2018 Feb; 167(3):635-648. PubMed ID: 29086231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
